Vietnam's New Cancer Drugs Face Access Hurdles, Hopes Rise with Insurance Expansion
Health

Vietnam's New Cancer Drugs Face Access Hurdles, Hopes Rise with Insurance Expansion

Access to the latest cancer drugs in Vietnam remains a significant challenge due to high costs. However, with the expansion of health insurance coverage, 84 new drugs, including 30 cancer treatments, are expected to be added to the insurance list by mid-next year, raising patient hopes.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.